Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2016 1
2019 2
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

4 results

Results by year

Filters applied: . Clear all
Page 1
Standardized classification and reporting of glomerulonephritis.
Sethi S, Fervenza FC. Sethi S, et al. Nephrol Dial Transplant. 2019 Feb 1;34(2):193-199. doi: 10.1093/ndt/gfy220. Nephrol Dial Transplant. 2019. PMID: 30124958 Review.
A kidney biopsy is done to determine the etiology of the glomerulonephritis (GN) and the severity of the lesion, to identify whether other lesions, related to or not related to the GN, are present on the kidney biopsy and finally to ascertain the extent of chronicity of th …
A kidney biopsy is done to determine the etiology of the glomerulonephritis (GN) and the severity of the lesion, to identify whether …
Understanding the complement-mediated glomerular diseases: focus on membranoproliferative glomerulonephritis and C3 glomerulopathies.
Lionaki S, Gakiopoulou H, Boletis JN. Lionaki S, et al. APMIS. 2016 Sep;124(9):725-35. doi: 10.1111/apm.12566. Epub 2016 Jun 30. APMIS. 2016. PMID: 27356907 Review.
An enhanced understanding of the role of complement in the pathogenesis of membranoproliferative glomerulonephritis has led to reclassification of the latter into immunoglobulin-mediated and non-immunoglobulin-mediated disease. The new cl …
An enhanced understanding of the role of complement in the pathogenesis of membranoproliferative glomerulonephritis has led to …
Rituximab use in adult glomerulopathies and its rationale.
Santos JE, Fiel D, Santos R, Vicente R, Aguiar R, Santos I, Amoedo M, Pires C. Santos JE, et al. J Bras Nefrol. 2020 Mar;42(1):77-93. doi: 10.1590/2175-8239-JBN-2018-0254. Epub 2019 Dec 20. J Bras Nefrol. 2020. PMID: 31904761 Free PMC article. Review.
Preliminary results support the use of RTX in patients with pure membranous LN and immunoglobulin-mediated membranoproliferative glomerulonephritis (MPGN), but not in patients with class III/IV LN or complement-mediated MPGN. No conclusion can be drawn …
Preliminary results support the use of RTX in patients with pure membranous LN and immunoglobulin-mediated membranoprolifer …
Pathogenesis of the C3 glomerulopathies and reclassification of MPGN.
Bomback AS, Appel GB. Bomback AS, et al. Nat Rev Nephrol. 2012 Nov;8(11):634-42. doi: 10.1038/nrneph.2012.213. Epub 2012 Oct 2. Nat Rev Nephrol. 2012. PMID: 23026947 Review.
Until recently, membranoproliferative glomerulonephritis (MPGN) was clinically classified as either primary, idiopathic MPGN or as secondary MPGN when an underlying aetiology was identifiable. ...An improved understanding of the role of complement in the pathogenesi …
Until recently, membranoproliferative glomerulonephritis (MPGN) was clinically classified as either primary, idiopathic MPGN o …